智云健康(09955.HK) 预计,截至2025年12月31日止年度录得介乎约8.8亿元至约9.8元人民币(下同)的综合净亏损,而于截至2024年12月31日止年度则录得综合净亏损约4.91亿元。预期亏损增加主要是由于集团进行战略转型重组业务模式,围绕核心人工智能能力,重点打造高质量及可产生现金流的增长。此导致就出售若干子公司确认大额减值亏损及录得与交易对手方正处于重大诉讼或接受司法调查的业务相关...
Source Link智云健康(09955.HK) 预计,截至2025年12月31日止年度录得介乎约8.8亿元至约9.8元人民币(下同)的综合净亏损,而于截至2024年12月31日止年度则录得综合净亏损约4.91亿元。预期亏损增加主要是由于集团进行战略转型重组业务模式,围绕核心人工智能能力,重点打造高质量及可产生现金流的增长。此导致就出售若干子公司确认大额减值亏损及录得与交易对手方正处于重大诉讼或接受司法调查的业务相关...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.